| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
in00002463513 |
| 005 |
20211202191134.0 |
| 006 |
m d f |
| 007 |
cr bn||||||||| |
| 008 |
090319s2009 mdu s f000 0 eng d |
| 035 |
|
|
|a (OCoLC)ocn316342011
|
| 040 |
|
|
|a GPO
|c GPO
|d GPO
|d CDS
|d GPO
|d MvI
|d UtOrBLW
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0499-T-02 (online)
|
| 086 |
0 |
|
|a HE 20.4802:P 49/DRAFT
|
| 245 |
0 |
0 |
|a Guidance for industry :
|b clinical pharmacology section of labeling for human prescription drug and biological products : content and format.
|
| 246 |
3 |
0 |
|a Clinical pharmacology section of labeling for human prescription drug and biological products
|
| 264 |
|
1 |
|a Rockville, MD :
|b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) :
|b Center for Biologics Evaluation and Research (CBER),
|c [2009]
|
| 300 |
|
|
|a 11 pages :
|b digital, PDF file.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Title from title screen (viewed on Mar. 19, 2009).
|
| 500 |
|
|
|a "Draft guidance."
|
| 500 |
|
|
|a "February 2009."
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Drugs
|x Labeling
|z United States.
|
| 650 |
|
0 |
|a Biological products
|x Labeling
|z United States.
|
| 710 |
2 |
|
|a Center for Drug Evaluation and Research (U.S.)
|
| 710 |
2 |
|
|a Center for Biologics Evaluation and Research (U.S.)
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS110438
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 6560e73d-11e0-3d05-838a-8379e8bb9725
|i c54bf398-4666-3e69-8734-d88016af3c2e
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4802:P 49
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.4802:P 49
|t 0
|l Available Online
|